Related Experiment Video
Updated: Jan 19, 2026

Cell Fate Reprogramming of Nematode Germ Cells into Neurons
Tox4 modulates cell fate reprogramming
Lotte Vanheer1, Juan Song1, Natalie De Geest1
1KU Leuven - University of Leuven, Department of Development and Regeneration, Herestraat 49, B-3000 Leuven, Belgium.
Abstract:
Reprogramming to induced pluripotency induces the switch of somatic cell identity to induced pluripotent stem cells (iPSCs). However, the mediators and mechanisms of reprogramming remain largely unclear. To elucidate the mediators and mechanisms of reprogramming, we used a siRNA-mediated knockdown approach for selected candidate genes during the conversion of somatic cells into iPSCs. We identified Tox4 as a novel factor that modulates cell fate through an assay that determined the efficiency of iPSC reprogramming. We found that Tox4 is needed early in reprogramming to efficiently generate early reprogramming intermediates, irrespective of the reprogramming conditions used. Tox4 enables proper exogenous reprogramming factor expression, and the closing and opening of putative somatic and pluripotency enhancers early during reprogramming, respectively. We show that the TOX4 protein assembles into a high molecular form. Moreover, Tox4 is also required for the efficient conversion of fibroblasts towards the neuronal fate, suggesting a broader role of Tox4 in modulating cell fate. Our study reveals Tox4 as a novel transcriptional modulator of cell fate that mediates reprogramming from the somatic state to the pluripotent and neuronal fate.This article has an associated First Person interview with the first author of the paper.
Related Concept Videos
02:59Cell Fate Reprogramming of Nematode Germ Cells into Neurons
Fate Mapping
This video reviews the concepts behind fate mapping, and then details a...
06:10Following Cell-fate in E. coli After Infection by Phage Lambda
14:08Blastomere Explants to Test for Cell Fate Commitment During Embryonic Development
07:53Single Cell Fate Mapping in Zebrafish
08:29Long-term Live-cell Imaging to Assess Cell Fate in Response to Paclitaxel

